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Organ-Specific Disease Provoked
by Systemic Autoimmunity
Vale´rie Kouskoff,*‡§ Anne-Sophie Korganow,*§ still do not know whether it is primarily autoimmune
or inflammatory in nature, whether there is an incitingVe´ronique Duchatelle,† Claude Degott,†
Christophe Benoist,* and Diane Mathis* infectious agent, self-antigen, or both, to what extent
initiation and progression depend on systemic versus*Institut de Ge´ne´tique et de Biologie
Mole´culaire et Cellulaire (CNRS/INSERM/ULP) joint-specific events, and whether the primary effectors
are T cells, B cells, or other leukocytes. Our uncertainty1 rue Laurent Fries
67404 Illkirch Cedex is compounded by two factors: diagnosis of RA is usu-
ally made only after the disorder has progressed ratherC. U. de Strasbourg
France far along its course, probably long after the inciting
events; and RA appears to be a very heterogeneous†Service d’Anatomie Pathologique
Hoˆpital Beaujon entity, with significant variation in age of onset, overall
severity, and pathology.92110 Clichy
France Clearly, attempts to understand and control rheuma-
toid arthritis would benefit greatly from a small animal
model that spontaneously and reproducibly develops a
resemblant disease. Here we describe a new mouseSummary
model of RA, generated fortuitously, and explore the
mechanism of pathogenesis.Rheumatoid arthritis (RA) is a chronic joint disease
characterized by leukocyte invasion and synoviocyte
activation followed by cartilage and bone destruction. Results
Its etiology and pathogenesis are poorly understood.
We describe a spontaneous mouse model of this syn- Generation of the KRN Transgenic Mouse Line
drome, generated fortuitously by crossing a T cell re- R28 is a T cell hybridoma that was derived from a
ceptor (TCR) transgenic line with the NOD strain. All B10A.4R mouse and recognizes the 41–61 peptide of
offspring develop a joint disease highly reminiscent of bovine pancreas ribonuclease (RNase) in the context of
RA in man. The trigger for the murine disorder is Ak (Peccoud et al., 1990). To study selection of the R28
chance recognition of a NOD-derived major histocom- specificity, we generated a transgenic mouse line car-
patibility complex (MHC) class II molecule by the rying the rearranged T cell receptor genes from the hy-
transgenic TCR; progression to arthritis involves bridoma. TCR-a and -b cDNAs were synthesized from
CD41 T, B, and probably myeloid cells. Thus, a joint- mRNA and were cloned and sequenced, revealing Va4
specific disease need not arise from response to a and Vb6 variable regions (S. Cande´ias, C. B., D. M.,
joint-specific antigen but can be precipitated by a unpublished data). The variable segments were inserted
breakdown in general mechanisms of self-tolerance into cassette genomic vectors containing homologous
resulting in systemic self-reactivity. We suggest that TCR transcription signals and known to direct efficient
human RA develops by an analogous mechanism. and specific expression in transgenic animals (Kouskoff
et al., 1995). Large TCR-a and -b genomic fragments
were coinjected into C57Bl/6(B6)xSJL F2 embryos, andIntroduction
a transgenic line, KRN, was established by repeatedly
back-crossing a founder carrying both genes to the B6Rheumatoid arthritis is a chronic inflammatory disease
of the synovial joints (Feldmann et al., 1996a, 1996b). A strain.
The KRN line was also crossed with various strainsmixed population of leukocytes invades the synovial
membrane and fluid, both normally devoid of blood- harboring the H-2k allele at the MHC in order to introduce
the appropriate restriction element, Ak, presumably re-derived cells; concomitantly, resident synovial macro-
phages and fibroblasts become activated and divide. quired for positive selection of the R28 specificity. The
resulting offspring expressed both transgene-encodedThe different leukocyte and synoviocyte constituents
produce a complex melange of cytokines and other sol- TCR chains on a large proportion of T lymphocytes in
the thymus and periphery, and a vigorous proliferativeuble mediators, which are thought to be responsible,
directly or indirectly, for the characteristic neovasculari- response could be elicited when their lymph node cells
were challenged with the bovine RNase41–61 peptide inzation, cartilage destruction, and bone erosion. Sys-
temic manifestations may ensue, including elevated the presence of Ak-expressing antigen presenting cells
(APCs) (Kouskoff, 1994; data not shown). Curiously,titers of autoantibodies in the blood, vasculitis, or abnor-
malities of other organs, e.g. the lung. though, the TCR transgenes did not promote skewing
of T cells into the mature CD41 compartment of eitherRA is an important disease, affecting a significant
portion (z1%) of the population and inflicting substantial the thymus or periphery of animals expressing Ak, as
was expected from previous results in analogous TCRpain and disability. It is also a mysterious disease. We
transgenic systems (Berg et al., 1989). In fact, by most
measures of positive selection, the T cell compartments‡Present address: National Jewish Center for Immunology and Re-
of animals on the “selecting” H-2k and “nonselecting”spiratory Medicine, 1400 Jackson Street, Denver, Colorado 80206.
§These authors contributed equally. H-2b backgrounds were quite similar, suggesting poor
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selection of transgene-encoded TCRs in both cases,
but some peripheral emergence of the R28 specificity,
nonetheless, probably due to “piggy-backing” with re-
ceptors encoded by endogenous TCR genes that had
bypassed allelic exclusion (Borgulya et al., 1992).
At that point, KRN did not appear to be a very useful
line: transgene-encoded TCRs were expressed quite ef-
ficiently, butwere ineffective at promoting allele-specific
positive selection. Fortunately, and quite fortuitously,
we also crossed KRN to the NOD strain.
Development of Arthritis in KRNxNOD Mice
When the KRN line was crossed with the NOD strain, a
surprising phenotype appeared in the offspring: trans-
gene-positive, but not transgene-negative, mice exhib-
ited pronounced joint inflammation (compare Figure 1A
right and left). In the transgene-positives, all of the distal
joints of the paws were swollen and red. As the animals
aged, a variety of deformations became evident—e.g.,
hyperextension of the ankle, valgus deviation of theFigure 1. Joint Swelling and Deformation
knee, hyperpronation of the toes (Figure 1B)—and the(A) Hind limbs of 6-week-old transgene-positive and -negative
KRNxNOD littermates. animals’ mobility was compromised, probably ex-
(B) Toe deformation at three months. plaining a reduced reproductive performance. Other-
(C) Ankle thickness followed over time in a cohort of KRNxNOD wise, their health appeared normal (including kidney
transgenics (KxN) and transgene-negative littermates (neg. litt.).
function and the quality of the skin and nails). Since thisEach solid line represents a single mouse. The dashed line shows
disease was ostensibly similar to rheumatoid arthritis,the maximum value for control mice at these ages.
we undertook an extensive characterization, assessing(D) Left (L) and right (R) ankles measured in parallel for three indi-
viduals. a diversity of clinical, histological and immunological
parameters.
Figure 2. Histology of Arthritis
(A–D) Hematoxylin-eosin-safran staining of knee sections of a normal mouse (A) and KRNxNOD transgenics after 1 day (B), three weeks (C),
or three months (D) of disease. ac, articular cavity; sl, synovial lining; ad, adipose tissue; arrow in (B), intraarticular cells and fibrinoid material.
(E) Hypervascularization and subsynovial infiltration at day 1. Arrows indicate vessels.
(F) Synovitis at 3 weeks. f, fibrosis.
(G) Pannus (pa) formation at 3 weeks. c, cartilage.
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Clinical Onset hip joint was unaffected, even in animals whose knees
were completely destroyed. Inflammation of the spineTo quantitate disease onset, we measured ankle thick-
was noted in some regions of some animals; however,ness in a cohort of transgene-positive and -negative
it differed markedly from the typical limb joint inflamma-littermates beginning shortly after birth. Figure 1C dem-
tion in its mild and variable appearance.onstrates a sharp onset of swelling at 25–35 days in the
Fluorescent antibody staining of cryostat sections offormer but not the latter. This panel also illustrates the
the knee joint revealed that the most abundant cell typescomplete penetrance of the disease; indeed, in the hun-
were of the macrophage lineage, identified by theirstain-dreds of animals by now examined, we have observed
ing with the MAC-1 and MOMA-1 markers (Figures 2Ijoint inflammation in all of the KRNxNOD TCR trans-
and 2J). T lymphocytes were less frequent, even at thegenics and none of the transgene-negative littermates
earliest stages of disease, and were usually found in(also see below). This was true whether the mice were
small clusters (Figure 2K); B cells were even rarer (nothoused under specific-pathogen-free or conventional
shown). Cytofluorimetric analysis of ankle synovial fluidconditions.
showed a somewhat different composition in the articu-Comparison of the curves for any two individuals in
lar cavity (Figure 2L). There was a minor population ofFigure 1C revealed a degree of heterogeneity in disease
small CD31 T lymphocytes (1%–3%) and a vast majorityinitiation and course. However, when curves for the two
of large Mac-1-positive cells. Most of these were neutro-limbs of individual animals were compared (Figure 1D),
phils, identified by their scatter profiles and strong stain-they were always precisely superimposable. Symmetry
ing with an anti-GR-1 mAb, but their was also a smallof involvement also appeared true of the other inflamed
component of GR-11/2, surface immunoglobulin (sIg)1joints, according to simple by-eye inspection.
cells. The paucity of lymphocytes in the joint was re-Joint Histology
flected in the profile of cytokines detected—by PCRTo visualize the pathological processes underlying
analyses of cells in the synovial fluid: undetectable in-these clinical manifestations, we performed histological
terleukin (IL)-4, barely measurable IL-2 and interferonanalysis of knee joints (Figure 2). In the joint from a
(IFN)-g, and high levels of tumor necrosis factor (TNF)-a;normal mouse (Figure 2A), the articular cavity was acel-
by ELISA assays of protein in the synovial liquid: unde-lular, the synovial lining a thin unicellular layer covering
tectable IL-4, IL-10, IFN-g, TNF-a,and granulocyte/mac-adipose and connective tissue, and thecartilage smooth
rophage-colony stimulating factor (GM-CSF), and enor-
and uniform. At disease onset in KRNxNOD mice (Figure
mous quantities of IL-6 (0.5–20 mg/ml) (not shown).
2B), the lesions were quite discrete: fibrinoid material
Skeletal preparations were made from animals three
and a few cells were found in the cavity; edema set in
to six months after disease onset to better document
under the synovial lining, accompanied by neovasculari-
the distribution and extent of bone destruction (Figure
zation and some infiltration of inflammatory cells (seen
3). Damage was massive in the paws (Figure 3A), affect-
better at higher power in Figure 2E); and bone and carti- ing all interphalangial, metatarsal, and tarsal joints (and
lage were largely unaffected. After a few weeks of evolu- their forelimb equivalents); the calcaneum was also
tion (Figure 2C), disease was marked by extensive syno- damaged. A close-up view of the interphalangial joints
vitis, affecting all areas of the joint. The synovium was (Figure 3B) depicts a typical image of bone erosion to-
hyperplastic, with massive infiltration of inflammatory gether with anarchic reconstruction; very similar pic-
cells and the beginnings of fibrosis (Figure 2F). In some tures were found with the knee joint (Figure 3C). In con-
areas, small nodules developed, seemingly composed trast, the sacro-iliac joint always appeared intact (Figure
of lymphocytes. Abundant fibrinoid material and inflam- 3D), as did the hip (Figure 3E). Consistent with the histo-
matory cells, mainly neutrophils in appearance, exuded logical findings described above, most of the vertebral
from the inflamed synovium into the articular cavity. The joints were unaffected, but signs of destruction were
synovitis extended over some areas of cartilage, forming detected sporadically (arrow in Figure 3F).
a typical pannus, which invaded the cartilage and under- Immunological Analysis
lying bone; chondrocytes in their niches were pyknotic Lastly, we examined immunological parameters af-
(Figure 2G). After several months of disease, the knee fected in certain of the human arthritides. Splenomegaly
joint presented an anarchic picture (Figure 2D). The in- was often noted, and B lymphocyte numbers were in-
flammatory process had largely receded, but the archi- creased in the lymph nodes and spleen of diseased
tecture of the joint was completely remodeled: little car- animals (on average 1.75-fold; n 5 7). However, B cells
tilage remained and the residual bone adopted irregular did not appear to be in an abnormal activation state as
structures, embedded in the massive fibrosis that now assessed by size, IgM/IgD profile, or staining intensity
made up most of the joint (Figure 2H). with anti-CD69, -CD5, or -MHC class II reagents (not
Similar lesions were detected in the distal joints of shown). In addition, the follicular organization (follicle,
the limbs of all KRNxNOD mice examined—including mantle zone, germinal centers) appeared entirely nor-
the metatarsal, tarsal, ankle and knee joints, and the mal. Hypergammaglobulinemia was also evident, essen-
tially due to an increase in the IgG1 isotype (Figure 4A).corresponding forelimb articulations. Interestingly, the
(H) Residual fibrosis (f) after 3 months. b, bone.
(I) Cryostat section of a knee synovium after one week of disease, stained with anti-MAC-1.
(J) As in (I), stained with anti-MOMA-1.
(K) As in (I), stained with anti-MAC-1 (green) and -CD3 (red).
(L) Cytofluorimetric analysis of synovial fluid cells. Inset, anti-GR1 versus anti-IgG staining on MAC-11CD32 gated cells.
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Figure 3. Selective Joint Destruction
Skeletal preparations after 5 months of disease. Extensive destruction in the paw compared with a negative littermate (A). Better visualized
at higher power on an interphalangial joint (B), and in the knee (C). Intact sacro-iliac (D) and hip (E) joints. Some intervertebral joints (F) were
affected (arrow), others largely intact.
Nonetheless, circulating antoantibodies could not be from crosses between B6 and other inbred strains
(BALB/c, DBA/2) showed no overt pathology.detected—including anti-dsDNA or rheumatoid factor
(RF; IgM anti-IgG) (Figure 4B) and antibodies capable The NOD strain is prone to autoimmune disease—
most notably diabetes, but also sialitis, thyroiditis, andof binding to sections of liver or kidney (not shown).
others (Tischand McDevitt, 1996). Both its peculiar MHCHowever, vast IgG deposits were observed on sections
allele, H-2g7, and multiple non-MHC genes play a role inof many organs, mainly along the basal membranes, in
promoting autoimmunity (Wicker et al., 1995). To distin-a pattern that is distinctly different from that observed
guish the contribution of MHC from non-MHC NOD-in diseases due to immune complex deposition, e.g. in
derived genes in our arthritis model, we crossed KRNMRL/lpr or NZBxNZW mice (Figures 4C–4G). IgG depos-
with a B6 line congenic for the NOD MHC. The offspringits were first seen some weeks after the initial signs of
(B6xB6.H-2g7) had one MHC allele originating from thearthritis and werenot associated with any other histolog-
B6 and one from the NOD strain; all non-MHC genesical abnormalities.
were B6-derived. These animals all showed overt signsAs will be discussed in detail below, the overall image
of arthritis (Table 1), indicating that the only requiredof disease in KRNxNOD mice—synthesized from diverse
contribution from the NOD genome was one H-2g7 allele.clinical, histological and immunological features—is
The NOD MHC is a complex recombinant haplotype,highly reminiscent of (though not identical to) rheuma-
carrying d-alleles on the H-2K end, an unusual alleletoid arthritis in human patients. Thus, although it was
(g7) at the Ab locus, and b-alleles on the H-2D end. Thatgenerated entirely unintentionally, we saw this as a po-
neither B6xBALB/c nor straight B6 transgene-positivetentially powerful model and have focused on unravel-
mice showed signs of pathology suggested that Kd, Aadling disease etiology and pathology.
(identical to Aag7) and Db were not sufficient in and of
themselves to engender disease. To evaluate the impor-
Genetic Contributions to Disease—the tance of Abg7, we introduced an additional transgene, a
NOD-Derived Abg7 Gene Is Primordial cDNA expression construct promoting display of Abg7
An important clue to the etiology of arthritis in the on all the usual class II–positive cells; since the
KRNxNOD model came from genetic analysis. As men- transgene was carried on the BALB/c background, an
tioned above and further detailed in Table 1, the TCR Aag7 (i.e. Aad) gene was introduced at the same time. All
transgenes did not engender pathology when carried B6xBALB/c F1s carrying both the TCR transgenes and
on a B6 genetic background. Disease was first manifest the Abg7 transgene developed arthritis, while none of the
in transgene-positive F1 offspring of a B6xNOD cross littermates carrying one or the other did (Table 1). The
and was universal in the hundreds of animals so far disease that developed in KRN mice carrying the Abg7
transgene resembled in all respects (penetrance, timeanalyzed. In contrast, transgene-positive F1 offspring
A TCR Transgenic Model of Rheumatoid Arthritis
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Table 1. Incidence of Disease Detected Correlated with Genetic
Background
Genetic Incidence of
Background Arthritis
B6 3 B6 0/150a
B6 3 NOD .300/300b
B6 3 BALB/c 0/7a
B6 3 DBA/2 0/17a
B6 3 B6.H-2nod 6/6b
B6 3 BALB/c.tgA bnod 10/10b
a No disease detected by inspection of the joints and by measure
of ankle thickness. The absence of inflammation was verified in
knee and ankle joints in some of these mice.
b Established by joint inspection and measure of ankle thickness,
and histological confirmation in several mice. Arthritis was strictly
dependent on the presence of the KRN transgene, and none of the
negative littermates were affected. In all three instances, disease
onset was between days 25 and 35.
arthritogenic antigen uniquely presented by this mole-
cule. During our initial attempts to test this notion, we
discovered that the R28 TCR actually responds to NOD
APCs alloreactively, i.e. in the absence of intentionally
added antigen. Stimulators could be splenic APCs from
NOD or B6.H-2g7 mice (Figure 5A) or a hybridoma be-
tween NOD splenocytes and the M12 B lymphoma line
(not shown); responders could be either the original T
hybridoma R28 (not shown) or lymph node T cells from
KRN transgenics on the B6 background (Figure 5A). The
alloresponse was always weaker than the reactivity to
bovine RNase peptide offered by Ak-expressing APCs.
That this alloreactivity is the basis for arthritis develop-
ment in KRNxNOD mice was strongly suggested by re-
sults from a series of crosses substituting other MHC
alleles in place of the NOD-derived (Figure 5B). There
was a perfect correlation between the appearance of
arthritis in the F1 offspring and allorecognition of theirFigure 4. B Lymphocyte Alterations
APCs by the R28 TCR.(A) Levels of circulating Ig isotypes in 8- to 20-week-old transgenics
(closed bars) normalized relative to negative littermates (open bars).
(B) Anti-DNA and -IgG autoantibodies in sera of transgenics, nega- T Cell Compartments in KRNxNOD Mice—Both
tive littermates, and a positive control MRL/lpr mouse. Central and Peripheral Tolerization Are
(C–G) Ig deposits detected by immunofluorescence with anti-IgG/ Evident, but Only Partial
FITC on cryostat sections. In the gut (C–E) IgG deposits were ob-
Its reactivity to APCs from NOD mice means that theserved in the submucosa and within the lamina propria of the villi,
transgene-encoded TCR has autoreactive potential inalong the subepithelial and pericapillary basal membranes; in the
KRNxNOD animals. Several examples of transgenicmuscle, deposits were in the connective areas of the endomysium
and perimysium around the fibers (F). In the kidney, there was some mouse lines carrying genes specifying autoreactive
IgG in the glomerulae, but most was found in the form of granular TCRs have been reported (Miller and Morahan, 1992). In
deposits along the peritubular basal membranes in the cortex and most of them, T lymphocytes expressing the transgene-
medulla (G). Cell nuclei in section (C) counterstained with propidium
encoded receptors were tolerized by one or moreiodide (red) highlighting the epithelial cell border. (A), (B), and (D),
means, e.g. clonal deletion, receptor or coreceptorlow power 1003 view. (C) and (E), 4003 on a confocal microscope.
down-modulation, anergy induction. We examined theAll from transgenics except (B), which was a negative littermate.
T cells in KRNxNOD animals to see whether they were
subject to analogous tolerization events.
Figure 6A compares numbers and CD4/CD8 profilescourse, histology) that in KRN mice harboring the entire
complement of NOD genes. of thymus and lymph node cells in different-aged
transgene-negative and -positive KRNxNOD mice. TheIt appears, then, that the NOD-derived MHC class II
molecule Ag7 is the element responsible for promoting youngest transgene-positive animals showed clear
signs of clonal deletion in the thymus, evidenced byarthritis in KRNxNOD mice.
reduced cell numbers and aberrant CD4/8 profiles. The
profiles progressively normalized thereafter, significantAlloreactive Recognition of NOD APCs by the R28
TCR Is the Key to Disease Development populations of mature single-positive cells being first
observed at 3 weeks of age, although cell numbers re-The critical and specific requirement for Ag7 suggested
that the transgene-encoded TCR might recognize an mained slightly subnormal. Clonal deletion in the thymus
Cell
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of cells showed intermediate or low levels (upper box).
Again, the reduced staining corresponded to cells ex-
pressing endogenously encoded (e.g. Vb81) receptors
(middle box) and, again, endogenously encoded Va2hi
receptors were easy to detect, predominantly on Vb6hi
cells (lower box). Introduction of the TCR-a null mutation
onto the B6xNOD background had two effects. As ex-
pected, T cells no longer displayed Va21 TCRs (lower
box)—the mutation permitted expression of transgene-
encoded Va4 only, so all cells expressed this and only
this Va. In addition, T cells displaying the highest levels
of Vb61 TCRs were much rarer (upper and middle boxes).
This implied that the CD41 T cells in KRNxNOD mice
could express high levels of one or the other of the
transgene-encoded chains, but usually not both. Hence,
it seems quite plausible that thymocytes expressing the
potentially autoreactive receptors escaped clonal dele-
tion because incomplete allelic exclusion permitted re-
arrangement and expression of endogenous TCR-a
and -b genes and thereby reduced levels of the
transgene-encoded specificity.
Many of the peripheral cells in weeks-old KRNxNOD
mice exhibited signs of prior activation (data not shown).
A greater proportion expressed late activation markers
(CD44hi, CD62Llo, CD45RBlo) than in transgene-negative
littermates (2–4 times), but there was only a small in-
crease in the fraction displaying early activation markers
(CD25hi, CD69hi).
Despite their increased expression of certain activa-
tion markers, the peripheral T cells from KRNxNOD mice
appeared functionally compromised: although normally
reactive to polyclonal stimulators like anti-CD3, they
Figure 5. Alloreactivity of the KRN Receptor and Its Relationship to exhibited only meager clonotypic reactivity. As illus-
Arthritis Development trated in Figure 7A, lymph node cells from B6 transgene-
(A) Lymph node cells from a KRN/B6 mouse were stimulated with positive animals made a vigorous response when of-
graded numbers of splenocytes (for B10.BR, supplemented with 25 fered bovine RNase 41–61 by APCs expressing Ak. In
mg/ml RNase 41–61 peptide); proliferation was measured after 48 hr. striking contrast, cells from transgene-positive B6xNOD
(B) Correlation between the arthitogenic potential of the KRN
animals responded very poorly, although a weak reactiv-transgene on different genetic backgrounds (the allele at the A locus
ity was reproducibly observed (in all of 5 experiments)of the MHC shown in parentheses) and alloreactive recognition by
at the highest peptide concentrations (inset). RNase-the KRN TCR, tested as in (A).
specific cells were poorly responsive rather than poorly
represented in KRNxNOD mice because the majority of
was reflected in the peripheral T cell compartments, as hybridomas derived from lymph node cells after poly-
single-positive lymph node and spleen cells also did not clonal stimulation with anti-CD3 produced IL-2 when
appear in significant numbers until after 3 weeks, and challenged with the bovine RNase peptide in the pres-
the CD41 population never reached normal size (3.1- ence of APCs expressing Ak (Figure 7B). Dose–response
fold average reduction, n 5 8; not shown). curves for hybridomas derived from transgene-positive
Figure 6B examines TCR usage on peripheral CD41 B6 and B6xNOD animals overlapped. Hybridomas that
cells of 7 week-old KRN transgenics carried on the B6 responded to the bovine RNase peptide presented by
versus B6xNOD genetic background, or on the B6xNOD Ak could also be stimulated alloreactively by NOD APCs
background bearing a homozygous null mutation of the (not shown).
endogenous TCR-a locus (Philpott et al., 1992). The goal Finally, although technically demanding, it was possi-
was to determine whether muted levels of the transgene- ble to examine the few T cells present in ankle synovial
encoded TCR might account for the ability of the poten- fluid. The most important observations were that: (1)
tially autoreactive T cells to escape from the thymus in there was a shift in the CD4/CD8 profile in comparison
older animals. In B6 mice, transgene-encoded Vb61 with that characteristic of lymph node, spleen, or blood
TCRs were expressed at high levels on most CD41 cells lymphocytes, with a marked enrichment for CD41 cells
(upper box); however, there was a shoulder of reduced (Figure 6C); (2) the CD41 population was enriched for
staining and this corresponded to cells displaying en- cells displaying high levels of the transgene-encoded
dogenously encoded Vbs (shown for Vb8 in the middle receptor (Figure 6D). (Although the latter observation
box). The lack of an appropriate reagent precluded might be taken as indicative of a clonotype-specific re-
quantitation of transgene-encoded Va41 receptors, but sponse in the joint, it is equally consistent with the ab-
endogenously encoded Va2hi TCRs were clearly detect- sence of a response and consequent TCR down-regula-
able (lower box). In B6xNOD mice, CD41 cells displaying tion.) Too few synovial fluid T cells could be isolated to
test their reactivity in vitro.high levels of Vb61 TCRs were seen, but now themajority
A TCR Transgenic Model of Rheumatoid Arthritis
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Figure 6. T Cell Compartments
(A) Thymocytes (Th) or splenocytes (Sp) from KxN transgenics and negative littermates or a KRNxB6 (KxB) mouse stained for CD4 and CD8.
The values in the thymus panels represent the total cell numbers 3 1026, those in the spleen panels, the percentages of CD41 cells.
(B) Gated CD41 splenocytes stained for transgene-encoded Vb6 (top panels; the [E] and [F] gates delineate high and intermediate Vb6 levels).
Coexpression of Vb6 with nontransgenic Vb8 or Va2 is shown on the dot-plots aligned below, the vertical line helping to visualize Vb6hi cells.
Shown are a KRN/B6 mouse (K), a KRNxNOD (KxN), or a KRNxNOD carrying a homozygous null mutation at the TCR-a locus.
(C) CD4/CD8 profile of T cells in the ankle synovial fluid of an arthritic mouse. Electronically gated as CD31MAC-12.
(D) Vb6 profile of gated CD41 cells in the spleen (Sp) or synovial fluid (SF).
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Figure 8. Requirement for CD41 T and B Cells for Arthritis Onset
(A) Transgenics were treated by intraperitoneal injection of the anti-
CD4 mAb YTS177 (Cobbold et al., 1990), titrated to block CD41
cells for three to four weeks, or vehicle only on the indicated days
(arrows). Disease progression was followed by measurement of
ankle thickness.
(B) As in (A), except that mice were followed over a longer period.
(C and D) As in (A), except that treatment was initiated later.
(E) The mMT8 mutation was introduced into KRNxNOD mice either
in the phenotypically normal heterozygous state (closed bars) or
the B cell–deficient homozygous state (open bars). Ankle thickness
was measured at 40 to 50 days. That all mMT homozygotes were
entirely free of disease was confirmed in five mice by histological
analysis.
into the periphery. Yet, the paltry clonotype reactivityFigure 7. Clonotypic Reactivity of T Cells
exhibited by lymph node T cells from KRNxNOD animals(A) Lymph node cells from various mice (abbreviations as in Figure
and the paucity of T cells in the arthritic lesion begged6) were challenged with bovine RNase 41–61 peptide presented by
B10.BR splenic APCs. The weak proliferation of KRNxNOD respond- for an independent confirmation of the importance of T
ers is highlighted in the inset, on an expanded scale. lymphocytes.
(B) T cell hybridomas prepared from the indicated mice were incu- To this end, we treated KRNxNOD mice about one
bated with bovine RNase 41–61 peptide and B10.BR splenic APCs.
week before the usual time of disease onset with aStimulation was measured as IL-2 production, read-out as prolifera-
nondepleting anti-CD4 mAb under conditions demon-tion of CTLL.
strated (not shown) to completely coat CD41 cells for 3
to 4 weeks. As indicated in Figure 8A, treatment ac-
cording to this protocol led to a complete block of dis-Taken together, the results on T cells from KRNxNOD
mice indicate that the potentially autoreactive specificity ease initiation. That the blockade was only temporary
is depicted in Figure 8B: about 5 to 6 weeks after anti-is subject to two levels of tolerance induction: clonal
deletion in the thymus and some form of anergy induc- CD4 treatment (and 4 to 5 weeks after disease routinely
sets in) arthritis began; this corresponded to the reemer-tion in the periphery. Clonal deletion was efficient only
until about 3 weeks of age; shortly afterwards, mature gence of substantial numbers of cells stainable with the
anti-CD4 mAb (not shown). Anti-CD4 had to be adminis-T cells with muted levels of the autoreactive receptor
escaped into the periphery and, nearly coincidently, the tered at least five days before disease onset to be effec-
tive; mice treated just at the time of (Figure 8C) or afterfirst signs of arthritis appeared.
(Figure 8D) initiation developed the usual arthritis.
Given the B lymphocyte abnormalities in both KRNThe Role of Lymphocytes in Disease
Development—CD41 T and B Cells xNOD mice and human RA patients, we evaluated the
influence of B cells on the development of arthritis in ourAre Required
The very nature of the KRNxNOD disease implies a criti- model. This was done by introducing the mMT8 mutation
(Kitamura et al., 1991) in homozygous form, preventingcal role for T lymphocytes, i.e. arthritis only appeared
when two elements were introduced onto the B6 back- the surface display of Ig heavy chains, resulting in the
absence of a mature B cell compartment. KRNxNODground: the TCR genes originating from the R28 hybrid-
oma and the Ag7 genes. In addition, disease was first mice devoid of B cells showed no signs of arthritis,
evaluated either by joint measurements (Figure 8E) ordetectable just after significant numbers of mature T
cells displaying transgene-encoded receptors emerged histological analyses (not shown). Although B cells were
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absent, T cellsdisplaying the transgene-encoded recep- parameters. The influence of genetics and environment
on the panoply of abnormalities is not understood attor underwent clonal deletion in the thymus, and
transgene-encoded receptor levels on peripheral T cells present; so it is quite conceivable that the disease in
genetically pure mice, housed in controlled environmen-were reduced as in KRNxNOD animals with a normal
complement of B cells (not shown). tal conditions, might not reproduce every aspect of the
disorder in patients. A related point is that the mouse
disease is more aggressive than the RA typically found
Discussion in man, such that sites remaining intact in the latter
(perhaps under the influenceof drug treatment) arecom-
A New Model of Rheumatoid Arthritis promised in the former.
KRNxNOD mice represent a new model of RA in man One needs also to situate the KRNxNOD strain in the
as they spontaneously develop a highly reminiscent dis- context of other models of RA (for reviews, see Hender-
ease. Just how good a model is it? son et al., 1995). A variety of induced small animal mod-
Arthritis in KRNxNOD mice shares most of the major els have been described, elicited by such agents as
clinical, histological and immunological features of the bacteria, viruses, adjuvants or cartilage components.
human disorder. It is a chronic progressive disease that On the other hand, few spontaneous models have been
is first manifest by swelling of the joints, and evolves reported and most of these have not been explored
to a point where multiple joint deformities significantly in great depth. Mice of the MRL/lpr strain, the most
impair mobility. Articular involvement is strikingly sym- extensively studied example to date, often show histo-
metrical and shows a marked distal preeminence, both logical, though rarely clinical, signs of polyarthritis, and
characteristics of the human syndrome. Histological exhibit high concentrations of circulating RF and other
analysis reveals the classical images of massive leuko- autoantibodies (Andrews et al., 1978). However, this is
cyte infiltration, synovitis, pannus formation, cartilage primarily a lymphoproliferative disease, due to an alter-
destruction, bone erosion followed by remodeling, and ation in the fas gene, and is probably more akin to sys-
fibrosis. Immunological evaluation demonstrates B lym- temic lupus erythrematosis than RA. DBA/1 mice can
phocyte dysregulation, evidenced by increased B cell spontaneously develop polyarthritis (Nordling et al.,
numbers and hypergammaglobulinemia. In addition, the 1992), but it is asymmetric, intermittent, and migratory,
critical dependence of the mouse disease on the MHC and shows little evidence of immune system involve-
class II Ag7 molecule recalls the long-studied influence ment. Two strains of mice exhibiting diseases reminis-
of particular class II alleles on the disorder in man cent of RA were recently engineered via transgenesis.
(Wordsworth, 1992). In one (Iwakura et al., 1991), the HTLV-1 genome was
Nonetheless, the arthritides of KRNxNOD animals and introduced; the animals develop a chronic polyarthritis,
human subjects differ in several details. Clinically, there but it is slow in onset and only partially penetrant (50%
are a few discrepancies in the pattern of joint involve- incidence at 1 year in females; even lower in males). In
ment: the mice show attack of the distal interphalangeal the other (Keffer et al., 1991), the transgene was a human
joints and, sporadically, inflammation of the spine, while TNF-a gene modified in the 39-untranslated region;
humans generally do not. Histologically, there may be these animals show a chronic, destructive polyarthritis
dissimilarities in the composition of the inflammatory at an early age with 100% incidence but, curiously, the
infiltrate, as the large excess of myeloid cells over T same disorder is exhibited by transgenics rendered de-
lymphocytes and plasma cells in the inflamed synovial void of an immune system (cited in Feldmann et al.,
membrane of KRNxNOD mice appears more extreme 1996a).
than usually described for patient material. (Although Thus, it would appear that the KRNxNOD model repre-
patient histology, itself, is highly variable, making it diffi- sents a potentially important tool for studying RA—both
cult to assess the real magnitude of this dissimilarity.) for exploring the mechanism of disease development
Immunologically, the most striking discordance is in the and for testing new therapeutic strategies. Its usefulness
profile of autoantibodies detected: RF, present at ele- should be enhanced by several features: 100% disease
vated concentrations in z70% of RA patients, is not incidence, an early and reproducible time of onset, a
observed in KRNxNOD animals; conversely, IgG depos- highly predictable disease course. In addition, its being
its coat many of the organs in the mouse model but a TCR transgenic system highlights and greatly simpli-
this has not been reported for patients. However, the fies the contribution made by lymphocytes and should
significance of RF and other autoantibodies in arthritis thus permit new approaches to dissecting the role of
pathology has beenquestioned (Feldmann etal., 1996b), the immune system in pathology.
and the murine/humandifferences could just reflect spe-
cies-specific variations in B cell physiology—variant
outcomes of massive B cell stimulation. The Mechanism of Arthritis Development
in KRNxNOD MiceIn evaluating the significance of these differences,
one should bear in mind several considerations. Mice The R28 T cell hybridoma responds alloreactively to
APCs from NOD mice due to recognition of the MHCand men obviously show dissimilarities in physiology—
perhaps most relevant here would be their divergent class II Ag7 molecule; consequently, T cells from mice
carrying rearranged TCR genes from R28 and Ag7 genespostures and modes of locomotion. Thus, it is not too
surprising that a disease of the joints might differ in from the NOD strain should exhibit systemic autoreactiv-
ity. That they do is readily apparent from an analysis ofdetails. In addition, RA in humans is a highly variable
syndrome, showing significant diversity in a number of T lymphocyte compartments in KRNxNOD mice. The
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thymus shows a clear deletion profile until 3 weeks of II molecule expression on a variety of cell types that
usually display none or little, including synoviocytes.age; around that time, mature T cells appear in the thy-
mus and periphery, although their numbers never quite Aberrant activation of these cells could then result from
recognition of their Ag7 molecules by the transgene-reach normal levels. Peripheral T cells are characterized
by a reduced display of the transgene-encoded TCR encoded TCR, and this activation might set off a
sequence of events leading to arthritis. It is highly(coupled with frequent expression of endogenously en-
coded receptors) and by poor responsiveness. Never- suggestive that MHC class II molecules are lymphokine-
inducible on macrophages and synovial fibroblasts andtheless, their emergence coincides with the first clinical
and histological signs of arthritis. Thus, one gets the that their engagement leads to the production of a vari-
ety of mediators, including TNF-a, IL-1b, nitric oxide,impression of autoreactivity that is largely contained,
but not totally eliminated, by multiple tiers of tolerance IL-6, and IL-8 (Alvaro-Gracia et al., 1989; Trede et al.,
1991; Mourad et al., 1992; Mehindate et al., 1994). Third,induction. Why deletion is so partial after 3 weeks is
unknown and will probably remain so until we learn more specificity could be imposed by the physiology of the
joint: it is poorly vascularized and subject to mechanicalabout the exact ligand recognized—Ag7 irrespective of
peptide? plus multiple peptides? plus a single peptide? stress, factors that might combine to create an environ-
ment of low oxidative state. Redox balance is known to(We do know that the ligand is not the corresponding
mouse RNase peptide presented by Ag7). Presumably, modulate the synthesis or activity of transcription fac-
tors expressed by T cells (Ivanov et al., 1993) and issome alteration in the population of thymic stromal cells
or in their expression of Ag7 or its peptide complement suspected to underlie the control that bcl-2 exerts on
apoptosis (Hockenbery et al., 1993). Thus, it is possibleoccurs around this time, perhaps related to the vast
hormonal changes taking place at weaning. That the that different programs unfold when T cells in the joint,
versus those in the lymphoid organs and other tissues,partiality of clonal inactivation may be key is suggested
by the KRNxDBA/2 cross, which introduced the mls1a are stimulated—in the former case, biased towards pro-
liferation and cytokine production; in the latter, towardssuperantigen: offspring exhibited clonal deletion more
extreme than that found in KRNxNOD mice and no signs anergy or death. Alternatively, or in addition, the poor
vacularization and mechanical stress of the joint couldof arthritis were apparent (Table 1).
The low level of systemic autoreactivity persisting in result in ineffectual clearance of immune complexes is-
suing from polyclonal B cell activation and, by conse-KRNxNOD mice is manifest as an organ-specific dis-
ease. Although we do not yet know how this comes quence, stimulation of the complement cascade and
induction of inflammatory cytokines.about, we do have in hand several pieces of information
that provide important leads. The anti-CD4 experiments Whatever the mechanism turns out to be, one aspect
should be highlighted—systemic autoreactivity can pro-demonstrate a critical role for CD41 T cells and further
reveal that they perform their required function(s) very voke an organ-specific disease. Wide distribution of the
inciting antigen/Ag7 complex is indicated by the deletionearly in disease course—anti-CD4 treatment just prior
to or after disease onset provides no benefit. The studies of immature T cells in the thymus and by the ability of
splenocytes to stimulate R28 T cells in vitro. That theon mice carrying the mMT8 mutation, and thereby lacking
a mature B lymphocyte compartment, show an impor- distribution does not just reflect the binding of circulat-
ing antigen by Ag7 displayed on APCs is suggested bytant role for B cells. This could be either as antibody
producers or as antigen presentors, or could reflect the finding that a B hybridoma derived from NOD spleno-
cytes and cultured for months also stimulates R28 cellssome more indirect function. Lastly, joint histology and
cytokine profiles argue for the involvement of cells of the in vitro.
myeloid lineage, perhaps as producers of inflammatory
factors such as TNF-a and IL-6.
Implications for the Mechanism(s) of DiseaseConsidered in their ensemble, these leads suggest sev-
Development in Other Models and Patientseral possible scenarios for the development of arthritis in
One is led to question whether the disease in other RAthe KRNxNOD model. First, the key to joint specificity
models or in RA patients might not arise from a similarcould lie in the abnormal activation of B lymphocytes:
systemic, rather than joint-specific, provocation.essentially all B cells constitutively display Ag7 and should
Certainly there are some models where the mecha-thus be recognized by T cells expressing the transgene-
nism of disease is likely to involve primarily systemicencoded TCR and be delivered “help” that is aberrant in
stimulation. For example, the arthritis in animals infectedits universality and route of delivery, i.e. independent of
by mycoplasma arthritides could unfold in a very similarthe Ig receptor.The outcome could be high level synthesis,
fashion to that in KRNxNOD mice. Upon infection, thiseither systemically or locally, of an unusual combination
microbe produces a superantigen, mycoplasma arthritisof lymphokinesand other mediators,which might promote
mitogen, which can bridge MHC molecules and TCRssynovitis and recruitment of leukocytes into the joint. Sec-
or directly trigger cells through their MHC molecules,ond, aberrant activation of a cell population residing in
thereby inciting polyclonal T and B cell activation andthe normal synovium could be the basis of joint specificity.
the production of inflammatory cytokines (TNF-a, IL-1,Polyclonal activation of both T and B lymphocytes should
IL-6) by monocytes. This superantigen has already beentake place in KRNxNOD mice due to mutual stimulation
directly implicated in arthritis exacerbation (Cole andvia the TCR–MHC class II molecule interaction, resulting
Sawitzke, 1995). Another model to consider in this con-in differentiation, lymphokine secretion, and altered
text is the transgenic mouse line carrying a modifiedhoming properties. The lymphokines produced, e.g.
IFN-g, TNF-a, IL-4, would be capable of inducing class human TNF-a gene (Keffer et al., 1991). These animals
A TCR Transgenic Model of Rheumatoid Arthritis
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Antibodies and Flow Cytometryexpress TNF-a in a deregulated fashion throughout the
Preparation of thymus, lymph node, and spleen cell suspensions,body and develop an arthritis apparently quite similar
their staining for flow cytometry, and the mAbs used were as de-to that in KRNxNOD mice, except that it appears to be
scribed (Cosgrove et al., 1991; Wang et al., 1996). Synovial fluid cell
independent of lymphocytes (cited in Feldmann et al., suspensions were made after several ankle punctures; the viscous
1996a). We suggest that the diseases in the two models fluid leaking out (3–20 ml) was diluted in PBS/EDTA and centrifuged.
Determination of circulating Ig levels was performed by ELISAmight depend on a similar mechanism of pathogenesis,
(Cosgrove et al., 1991). Assays for autoantibodies included immuno-but that the TNF-a transgenic model just initiates further
fluorescence on cryostat sections of mouse liver and kidney (1/50downstream, after any inciting systemic autoreaction.
serum dilutions, goat anti-mouse-IgG/FITC second step), ELISA withThe HTLV-1 transgenic model (Iwakura et al., 1991)
dsDNA or mouse IgG as target antigens (with goat-anti-mouse-
might also fit somewhere along this pathway, as high IgG1M/phosphatase or anti-mouse-IgM/peroxydase as second
levels of IL-1, probably induced by the virally encoded steps).
Tax protein, have been reported in these animals.
HistologyThere are also suggestions that systemic reactivity
Joints were fixed in 4% paraformaldehyde, decalcified for 8 hr inmight play a role in human rheumatoid arthritis. Quite
6% nitric acid followed by 8 hr in 4% paraformaldehyde (treatmentanalogous to the observations on KRNxNOD mice are
repeated twice), and embedded in paraffin; 2 mm sections were
recent findings that a significant fraction of synovial T stained with hematoxylin/eosin/safran. Immunostaining of cryostat
cells from several patients recognize antigens ex- sections was performed as described (Cosgrove et al., 1991), with
pressed by autologous APCs (David-Ameline et al., mAbs M1/70-FITC (Pharmingen), BM8 or MOMA-1 (Kraal and Janse,
1986) orKT3 (developedwith anti-rat-IgG/Texas red), oranti-mouse-1996; Schmidt et al., 1996), in particular B cell antigens
IgG/FITC. For skeletal preparations, limbs or fragments were fixedencoded by Epstein-Barr virus (Scotet et al., 1996). In
overnight in 1% glacial acetic acid, 95% ethanol, stained for carti-addition, TCR Vb usage in certain patients suggests lage with fresh Alcian blue solution (80 ml 95% EtOH, 20 ml glacial
stimulation by superantigens (reviewed in Cole and Sa- acetic acid, 15 mg Alcian blue) for 48 hr. After dehydratation in 95%
witzke, 1995). In such cases, polyclonal activation and ethanol for a day, soft tissues were dissolved in 2% KOH for a few
expansion of T cells could be coupled to a massive hours at 378C. Bones were stained in 1% KOH, 75 mg/ml Alizarin
red overnight, destained in 20% glycerol, 1% KOH for 7–15 days.reciprocal activation of B cells and, as discussed above,
Remaining loose tissues were dissected away and the preparationsthis could be a trigger for arthritis development. In this
stored into 50% glycerol, 50% EtOH.context, it might be worth reconsidering the basis for
RA association with particular MHC alleles: some alleles,
T Cell Stimulation and Hybridomas
due to peculiarities of expression or protein structure, Lymph node T cells were cultured at 3 3 105/well in 96-well plates
could more readily provoke stimulation of autologous T in RPMI-1640 medium supplemented with 1 mM glutamine, 50 mM
cells. 2-ME and 10% FCS, for 36–48 hr at 378C. Proliferation was detected
by 3H-thymidine incorporation in the last 12 hr of culture. The KRNThus, it is quite possible that the mechanism of dis-
receptor was stimulated by varying doses of peptide 41–61 of bovineease in KRNxNOD mice does accurately reflect that in
pancreatic RNase (Peccoud et al., 1990) or with B6xNOD orRA patients. On the other hand, we know of no compel-
B6xB6.H2g7 splenocytes.
ling evidence for the involvement of joint-specific anti- The M12xNOD hybrid cell line was obtained by PEG fusion of
gens in the human disorder. The challenge now is to fill LPS-blasts (24 hr culture) with the M12 B lymphoma line; hybrids
in the missing mechanistic details of the mouse model in were selected in HAT medium and by flow cytometry after staining
with the anti-Abg7 mAb 10.2.16 (C. Ebel, unpublished).order to elaborate the complete pathway from systemic
To derive T cell hybridomas from the transgenic mice, spleen orprovocation to joint-specific disease.
lymph node cells were stimulated with anti-CD3 for 24 hr in vitro,
fused to BW5147a-b-, and the hybrids selected in HAT medium.
These hybridomas were tested for IL-2 production after 24 hr stimu-Experimental Procedures
lation in the presence of 3 3 105 B10.BR splenocytes and RNase
peptide 41–61, or of graded numbers of NOD splenocytes. IL-2Mice
production was detected by incorporation of 3H-thymidine by theThe Abg7 transgenic line on the BALB/c background was a gift from
CTLL indicator line.D. Wherrett and H. McDevitt. The B6.H2g7 congenic line was pro-
vided by H. Kikutani. The mMT8 and TCRa8 knockout lines (Kitamura
Acknowledgmentset al., 1991; Philpott et al., 1992), gifts from K. Rajewsky and M.
Owen, were back-crossed in parallel onto the B6 and NOD/Lt back-
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